RIASTAP
RIASTAP
Approved
DIN Number
02393352
Drug Class
Human
Market Date
Jan 31, 2013
Company
HC
csl behring canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02393352
AIG Number0153289001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BB01 FIBRINOGEN, HUMAN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
FIBRINOGEN (HUMAN)Active
Strength: 1000 MG / VIAL
Monograph: FIBRINOGEN (HUMAN)